Hints and tips:
Related Special Reports
...To the people at First Baptist, it seemed to be a one-off tragedy....
...The company recently raised $100m in a round that was led by Fresenius Medical Care Ventures and included participation from existing investors such as Arch Venture partners and Khosla Ventures....
...Just ask German healthcare company Fresenius Medical Care. Its shares dropped 16 per cent on Wednesday after a profit warning....
...German healthcare group Fresenius Medical Care is making a push to become a leader in home dialysis treatment, by purchasing Boston-based medical technology and services company NxStage Medical for €1.7bn...
...German healthcare group Fresenius Medical Care has agreed to buy Boston-based medical technology and services company NxStage Medical for €1.7bn in cash....
...(Vifor Fresenius Medical Care has the deal for marketing rights outside the US.)...
...When Ben Lipps stepped down as chief executive of Fresenius Medical Care, the German maker of kidney dialysis equipment, in 2012 after 14 years at the helm, he was planning to settle into a relaxed retirement...
...The study argued that hydroxyethyl starch given to patients in intensive care offered no greater benefit than the alternative of saline, while increasing the risk of kidney problems....
...Yet, as the 9 per cent slump in shares of Fresenius Medical Care on Tuesday showed, they remain vulnerable to events....
...Baxter has long specialised in home-based dialysis, and the acquisition would expand its influence in hospital-based care....
...The companies likely to be competing for the final stage of the contract are all large non-UK corporations: Davita of the US, Fresenius Medical Care of Germany and Diaverum of Sweden....
...Analysts said the company, whose subsidiary Fresenius Medical Care is the world’s leading service provider of kidney dialysis treatment, might look to consolidate its grip over the sector in the US through...
...Fresenius Medical Care, the kidney dialysis specialist, gained 5 per cent to €35.15, on expectations of a draft US bill that could extend Medicare coverage for dialysis patients....
...Fresenius Medical Care, which provides kidney dialysis services to 10 per cent of patients worldwide, rose 2.3 per cent to €33.97 as fears about the impact of new US Medicare restrictions receded....
...Jimmy Yates, a trader at CMC Markets, said Fresenius Medical Care’s gains were purely speculative, based on legislation that has yet to be passed....
...Fresenius Medical Care gained 1.6 per cent to €91.34 following US government proposals for changes to the treatment of kidney dialysis which will double the amount of time – to 60 months – that private...
...The $50bn-a-year global dialysis market witnessed its second major acquisition in six months on Wednesday, with news that Germany’s Fresenius Medical Care will buy the fourth-largest US player and thus cement...
...Fresenius Medical Care found its shares topping and tailing the FTSE Eurofirst 300 at one point on Wednesday....
International Edition